Arkolith/Insider Trading/PRAH/Form 4

Gaenzle Christopher L

EVP, CAO & General CounselPRA Health Sciences, Inc. (PRAH) · full profile →Form 4 · filed Jun 3, 2021
Net Selling
Open-Market Buys
$0
Open-Market Sells
$145K
Net Open-Market Flow
-$145K
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 1, 2021Sell(S)850$170.45$145K36K
Jun 1, 2021Grant(A)3K—$037K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 1, 2021Grant(A)14K—$014K
Jun 1, 2021Option exercise(M)3K—$06K

Transaction Codes

S
Open-market sale
A
Grant / award
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-21-076347) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML